Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 1760Sesión 2026

Health Care Coverage

S 1760 c2

El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.

Florida Senate - 2026 CS for CS for SB 1760 By the Committees on Appropriations; and Health Policy; and Senators Brodeur, Gaetz, Rouson, Massullo, Garcia, and Harrell 576-03338-26 20261760c2 1 A bill to be entitled 2 An act relating to health care coverage; amending s. 3 1.01, F.S.; defining the term “Joint Legislative 4 Committee on Medicaid Oversight”; creating s. 11.405, 5 F.S.; establishing the Joint Legislative Committee on 6 Medicaid Oversight for specified purposes; providing 7 for membership, subcommittees, and meetings of the 8 committee; specifying duties of the committee; 9 authorizing the committee to submit periodic reports 10 to the Legislature; requiring the Auditor General and 11 the Agency for Health Care Administration to enter 12 into and maintain a data sharing agreement for a 13 certain purpose by a specified date; requiring the 14 Auditor General to assist the committee by providing 15 certain staff or consulting services; requiring state 16 agencies, political subdivisions of the state, and 17 entities contracted with state agencies to give the 18 committee access to certain records, papers, and 19 documents; authorizing the committee to compel 20 testimony and evidence according to specified 21 provisions; providing for additional powers of the 22 committee; providing that certain joint rules of the 23 Legislature apply to the proceedings of the committee; 24 requiring the agency to notify the committee of 25 certain changes and provide a report containing 26 specified information to the committee; requiring the 27 agency to submit a copy of certain reports to the 28 committee; amending s. 409.962, F.S.; defining terms; 29 amending s. 409.967, F.S.; revising encounter data 30 reporting requirements for prepaid Medicaid plans; 31 requiring that the agency’s analysis of such encounter 32 data include identification of specified occurrences; 33 requiring the agency to use such analysis in setting 34 managed care plan capitation rates; requiring that 35 managed care plan contracts require any third-party 36 administrative entity contracted with the plan to 37 adhere to specified requirements; specifying 38 additional types of payments which may not be included 39 in calculating income for purposes of the achieved 40 savings rebate; requiring, rather than authorizing, 41 the agency to calculate the medical loss ratio for all 42 managed care plans under certain circumstances; 43 revising requirements for the calculation of medical 44 loss ratios; requiring the agency to report medical 45 loss ratios quarterly and annually for each managed 46 care plan to the Governor and the Legislature within a 47 specified timeframe; requiring the agency to ensure 48 oversight of affiliated entities and related parties 49 paid by managed care plans; requiring the agency to 50 examine specified records and data related to such 51 entities and parties; requiring the agency to consider 52 certain data and findings when developing managed care 53 plan capitation rates; revising the income sharing 54 ratios used to calculate the achieved savings rebate 55 beginning on a specified date; creating s. 409.9675, 56 F.S.; requiring managed care plans to report to the 57 agency and the Office of Insurance Regulation the 58 existence of and specified details relating to certain 59 affiliations by a specified date and annually 60 thereafter; requiring managed care plans to report any 61 change in such information to the agency and the 62 office in writing within a specified timeframe; 63 requiring the agency to calculate, analyze, and 64 publicly report on the agency’s website an assessment 65 of affiliated entity payment transactions in the 66 Medicaid program and certain administrative costs by a 67 specified date and annually thereafter; providing 68 requirements for the assessment; amending s. 626.8825, 69 F.S.; defining the term “affiliated manufacturer”; 70 revising the definition of the term “pharmacy benefits 71 plan or program”; revising requirements for contracts 72 between a pharmacy benefit manager and a participating 73 pharmacy; revising the frequency of and deadlines for 74 certain reports pharmacy benefit managers are required 75 to submit to the office beginning on a specified date; 76 amending s. 626.8827, F.S.; revising and specifying 77 additional practices pharmacy benefit managers are 78 prohibited from engaging in; amending s. 627.42392, 79 F.S.; conforming a cross-reference; providing 80 effective dates. 81 82 Be It Enacted by the Legislature of the State of Florida: 83 84 Section 1. Effective upon this act becoming a law, 85 subsection (20) is added to section 1.01, Florida Statutes, to 86 read: 87 1.01 Definitions.—In construing these statutes and each and 88 every word, phrase, or part hereof, where the context will 89 permit: 90 (20) The term “Joint Legislative Committee on Medicaid 91 Oversight” means a committee or committees designated by joint 92 rule of the Legislature, by the President of the Senate or the 93 Speaker of the House of Representatives, or by agreement between 94 the President of the Senate and the Speaker of the House of 95 Representatives. 96 Section 2. Effective upon this act becoming a law, section 97 11.405, Florida Statutes, is created to read: 98 11.405 Joint Legislative Committee on Medicaid Oversight. 99 The Joint Legislative Committee on Medicaid Oversight is created 100 to ensure that the state Medicaid program is operating in 101 accordance with the Legislature’s intent and to promote 102 transparency and efficiency in government spending. 103 (1) MEMBERSHIP; SUBCOMMITTEES; MEETINGS.— 104 (a) The committee shall be composed of five members of the 105 Senate appointed by the President of the Senate and five members 106 of the House of Representatives appointed by the Speaker of the 107 House of Representatives, with each member serving a 2-year 108 term. The chair and vice chair shall each be appointed for 1 109 year terms, with the appointments alternating between the 110 President of the Senate and the Speaker of the House of 111 Representatives. The chair and vice chair may not be members of 112 the same house of the Legislature. If both the chair and vice 113 chair are absent from any meeting, the members present must 114 elect a temporary chair by a majority vote. 115 (b) Members shall serve without compensation but may be 116 reimbursed for per diem and travel expenses pursuant to s. 117 112.061. 118 (c) The chair may establish subcommittees as needed to 119 fulfill the committee’s duties. 120 (d) The committee shall convene at least twice a year, and 121 as often as necessary to conduct its business as required under 122 this section. Meetings may be held through teleconference or 123 other electronic means. 124 (2) COMMITTEE DUTIES.— 125 (a) The committee shall evaluate all aspects of the state 126 Medicaid program related to program financing, quality of care 127 and health outcomes, administrative functions, and operational 128 functions to ensure that the program is providing transparency 129 in the provision of health care plans and providers, ensuring 130 Medicaid recipients have access to quality health care services 131 and providing stability to the state’s budget through a health 132 care delivery system designed to contain costs. 133 (b) The committee shall identify and recommend policies 134 that limit Medicaid spending growth while improving health care 135 outcomes for Medicaid recipients. In developing its 136 recommendations, the committee shall do all of the following: 137 1. Evaluate legislation for its long-term impact on the 138 state Medicaid program. 139 2. Review data submitted to the Agency for Health Care 140 Administration by the Medicaid managed care plans pursuant to 141 statutory and contract requirements, including, but not limited 142 to, timeliness of provider credentialing, timely payment of 143 claims, rate of claim denials, prior authorizations for 144 services, and consumer complaints. 145 3. Review the Medicaid managed care plans’ encounter data, 146 financial data, and audits and the data used to calculate the 147 plans’ achieved savings rebates and medical loss ratios. 148 4. Review data related to health outcomes of Medicaid 149 recipients, including, but not limited to, Healthcare 150 Effectiveness Data and Information Set measures developed by the 151 National Committee for Quality Assurance, for each Medicaid 152 managed care plan, each Medicaid managed care plan’s performance 153 improvement projects, and outcome data related to all quality 154 goals included in the Medicaid managed care organization 155 contracts to improve quality for recipients. 156 5. Identify any areas for improvement in the laws and rules 157 relating to the state Medicaid program. 158 6. Develop a plan of action for the future of the state 159 Medicaid program. 160 (c) The committee may submit periodic reports, including 161 recommendations, to the Legislature on issues related to the 162 state Medicaid program and any affiliated programs. 163 (3) COOPERATION.— 164 (a) The Auditor General and the Agency for Health Care 165 Administration shall enter into and maintain a data sharing 166 agreement by July 1, 2026, to ensure the committee has full 167 access to all data needed to fulfill its responsibilities. 168 (b) The Auditor General shall assist the committee in its 169 work by providing credentialed professional staff or consulting 170 services, including, but not limited to, an actuary not 171 associated with the state Medicaid program or any Medicaid 172 managed care organization who currently has a contract with the 173 state. 174 (c) The committee, in the course of its official duties, 175 must be given access to any relevant record, paper, or document 176 in possession of a state agency, any political subdivision of 177 the state, or any entity engaged in business or under contract 178 with a state agency, and may compel the attendance and testimony 179 of any state official or employee before the committee or secure 180 any evidence as provided in s. 11.143. The committee may also 181 have any other powers conferred on it by joint rules of the 182 Senate and the House of Representatives, and any joint rules of 183 the Senate and the House of Representatives applicable to joint 184 legislative committees apply to the proceedings of the committee 185 under this section. 186 (4) AGENCY REPORTS.— 187 (a) Before implementing any change to the Medicaid managed 188 care capitation rates, the Agency for Health Care Administration 189 shall notify the committee of the change and appear before the 190 committee to provide a report detailing the managed care 191 capitation rates and administrative costs built into the 192 capitation rates. The report must include the agency’s 193 historical and projected Medicaid program expenditure and 194 utilization trend rates by Medicaid program and service category 195 for the rate year, an explanation of the manner in which the 196 trend rates were calculated, and the policy decisions that were 197 included in setting the capitation rates. 198 (b) If the Agency for Health Care Administration or any 199 division within the agency is required by law to report to the 200 Legislature or to any legislative committee or subcommittee on 201 matters relating to the state Medicaid program, the agency must 202 also submit a copy of the report to the committee. 203 Section 3. Present subsections (2) through (5), (6) through 204 (10), and (11) through (18) of section 409.962, Florida 205 Statutes, are redesignated as subsections (3) through (6), (8) 206 through (12), and (14) through (21), respectively, and new 207 subsections (2), (7), and (13) are added to that section, to 208 read: 209 409.962 Definitions.—As used in this part, except as 210 otherwise specifically provided, the term: 211 (2) “Affiliate,” including the terms “affiliated with” and 212 “affiliation,” means a person, as construed in s. 1.01(3), who: 213 (a) Directly or indirectly, through one or more 214 intermediaries, controls, is controlled by, or is under common 215 control with a specified entity or person, including parent and 216 subsidiary entities; or 217 (b) Is deemed a “related party” according to the standards 218 adopted by the Financial Accounting Standards Board. 219 (7) “Control,” including the terms “controlling,” 220 “controlled by,” and “under common control with,” means the 221 possession, direct or indirect, of the power to direct or cause 222 the direction of the management and policies of a person, 223 whether through the ownership or voting securities, by contract 224 other than a commercial contract for goods or nonmanagement 225 services, or otherwise, unless the power is the result of an 226 official position with or corporate office held by the person. 227 This definition applies regardless of whether such power is 228 affirmative or negative or whether such power is actually used. 229 Control is presumed to exist, but is not limited to, when any 230 affiliate or person, as construed in s. 1.01(3): 231 (a) Directly or indirectly owns, controls, holds the power 232 to vote, or holds proxies representing 10 percent or more of any 233 class of the voting securities of any other person. 234 (b) Shares common ownership with any person; has an 235 investor or is a holder of an ownership interest in any person; 236 exercises control in any manner over the election of a majority 237 of the directors or of individuals exercising similar functions 238 of any person; has the power to exercise controlling influence 239 over the management of any person; or serves as a working 240 majority of the board of directors, the managers, or the 241 officers of a person, who is: 242 1. A provider or a member of a provider group or group 243 practice as defined in s. 456.053(3) under the managed care 244 plan; or 245 2. A person responsible for providing any pharmacy 246 services, pharmaceuticals, diagnostics, care coordination, care 247 delivery, health care services, medical equipment, 248 administrative services, or financial services under the managed 249 care plan. 250 (13) “Market rate” means the price that a willing buyer 251 will pay and a willing seller will accept in an arm’s-length 252 transaction which is beneficial to both parties. 253 Section 4. Subsections (1) and (2), paragraph (h) of 254 subsection (3), and subsection (4) of section 409.967, Florida 255 Statutes, are amended, and subsection (5) is added to that 256 section, to read: 257 409.967 Managed care plan accountability.— 258 (1) CONTRACT PROCUREMENT PROCESS.—Beginning with the 259 contract procurement process initiated during the 2023 calendar 260 year, the agency shall establish a 6-year contract with each 261 managed care plan selected through the procurement process 262 described in s. 409.966. A plan contract may not be renewed; 263 however, the agency may extend the term of a plan contract to 264 cover any delays during the transition to a new plan. The agency 265 shall extend until December 31, 2024, the term of existing plan 266 contracts awarded pursuant to the invitation to negotiate 267 published in July 2017. 268 (2) CONTRACT REQUIREMENTS.—The agency shall establish such 269 contract requirements as are necessary for the operation of the 270 statewide managed care program. In addition to any other 271 provisions the agency may deem necessary, the contract must 272 require: 273 (a) Physician compensation.—Managed care plans are expected 274 to coordinate care, manage chronic disease, and prevent the need 275 for more costly services. Effective care management should 276 enable plans to redirect available resources and increase 277 compensation for physicians. Plans achieve this performance 278 standard when physician payment rates equal or exceed Medicare 279 rates for similar services. The agency may impose fines or other 280 sanctions on a plan that fails to meet this performance standard 281 after 2 years of continuous operation. 282 (b) Emergency services.—Managed care plans shall pay for 283 services required by ss. 395.1041 and 401.45 and rendered by a 284 noncontracted provider. The plans must comply with s. 641.3155. 285 Reimbursement for services under this paragraph is the lesser 286 of: 287 1. The provider’s charges; 288 2. The usual and customary provider charges for similar 289 services in the community where the services were provided; 290 3. The charge mutually agreed to by the entity and the 291 provider within 60 days after submittal of the claim; or 292 4. The Medicaid rate, which, for the purposes of this 293 paragraph, means the amount the provider would collect from the 294 agency on a fee-for-service basis, less any amounts for the 295 indirect costs of medical education and the direct costs of 296 graduate medical education that are otherwise included in the 297 agency’s fee-for-service payment, as required under 42 U.S.C. s. 298 1396u-2(b)(2)(D). For the purpose of establishing the amounts 299 specified in this subparagraph, the agency shall publish on its 300 website annually, or more frequently as needed, the applicable 301 fee-for-service fee schedules and their effective dates, less 302 any amounts for indirect costs of medical education and direct 303 costs of graduate medical education that are otherwise included 304 in the agency’s fee-for-service payments. 305 (c) Access.— 306 1. The agency shall establish specific standards for the 307 number, type, and regional distribution of providers in managed 308 care plan networks to ensure access to care for both adults and 309 children. Each plan must maintain a regionwide network of 310 providers in sufficient numbers to meet the access standards for 311 specific medical services for all recipients enrolled in the 312 plan. The exclusive use of mail-order pharmacies may not be 313 sufficient to meet network access standards. Consistent with the 314 standards established by the agency, provider networks may 315 include providers located outside the region. Each plan shall 316 establish and maintain an accurate and complete electronic 317 database of contracted providers, including information about 318 licensure or registration, locations and hours of operation, 319 specialty credentials and other certifications, specific 320 performance indicators, and such other information as the agency 321 deems necessary. The database must be available online to both 322 the agency and the public and have the capability to compare the 323 availability of providers to network adequacy standards and to 324 accept and display feedback from each provider’s patients. Each 325 plan shall submit quarterly reports to the agency identifying 326 the number of enrollees assigned to each primary care provider. 327 The agency shall conduct, or contract for, systematic and 328 continuous testing of the provider network databases maintained 329 by each plan to confirm accuracy, confirm that behavioral health 330 providers are accepting enrollees, and confirm that enrollees 331 have access to behavioral health services. 332 2. Each managed care plan must publish any prescribed drug 333 formulary or preferred drug list on the plan’s website in a 334 manner that is accessible to and searchable by enrollees and 335 providers. The plan must update the list within 24 hours after 336 making a change. Each plan must ensure that the prior 337 authorization process for prescribed drugs is readily accessible 338 to health care providers, including posting appropriate contact 339 information on its website and providing timely responses to 340 providers. For Medicaid recipients diagnosed with hemophilia who 341 have been prescribed anti-hemophilic-factor replacement 342 products, the agency shall provide for those products and 343 hemophilia overlay services through the agency’s hemophilia 344 disease management program. 345 3. Managed care plans, and their fiscal agents or 346 intermediaries, must accept prior authorization requests for any 347 service electronically. 348 4. Managed care plans serving children in the care and 349 custody of the Department of Children and Families must maintain 350 complete medical, dental, and behavioral health encounter 351 information and participate in making such information available 352 to the department or the applicable contracted community-based 353 care lead agency for use in providing comprehensive and 354 coordinated case management. The agency and the department shall 355 establish an interagency agreement to provide guidance for the 356 format, confidentiality, recipient, scope, and method of 357 information to be made available and the deadlines for 358 submission of the data. The scope of information available to 359 the department shall be the data that managed care plans are 360 required to submit to the agency. The agency shall determine the 361 plan’s compliance with standards for access to medical, dental, 362 and behavioral health services; the use of medications; and 363 follow-up followup on all medically necessary services 364 recommended as a result of early and periodic screening, 365 diagnosis, and treatment. 366 (d) Quality care.—Managed care plans shall provide, or 367 contract for the provision of, care coordination to facilitate 368 the appropriate delivery of behavioral health care services in 369 the least restrictive setting with treatment and recovery 370 capabilities that address the needs of the patient. Services 371 shall be provided in a manner that integrates behavioral health 372 services and primary care. Plans shall be required to achieve 373 specific behavioral health outcome standards, established by the 374 agency in consultation with the department. 375 (e) Encounter data.—The agency shall maintain and operate a 376 Medicaid Encounter Data System to collect, process, store, and 377 report on covered services provided to all Medicaid recipients 378 enrolled in prepaid plans. 379 1. Each prepaid plan must comply with the agency’s 380 reporting requirements for the Medicaid Encounter Data System. 381 Prepaid plans must submit encounter data, including data on 382 encounters for which payment was denied and encounters for which 383 a health care provider was reimbursed by the plan on a capitated 384 basis, electronically in a format that complies with the Health 385 Insurance Portability and Accountability Act provisions for 386 electronic claims and in accordance with deadlines established 387 by the agency. Prepaid plans must certify that the data reported 388 is accurate and complete. 389 2. The agency is responsible for validating the data 390 submitted by the plans. The agency shall develop methods and 391 protocols for ongoing analysis of the encounter data that 392 adjusts for differences in characteristics of prepaid plan 393 enrollees to allow comparison of service utilization among plans 394 and against expected levels of use. The analysis shall be used 395 to identify possible cases of overspending on administrative 396 costs, payments by plans in excess of market rates, systemic 397 underutilization or denials of claims and inappropriate service 398 utilization such as higher-than-expected emergency department 399 encounters, and potential managed care plan fraud, waste, and 400 abuse. The analysis shall provide periodic feedback to the plans 401 and enable the agency to establish corrective action plans when 402 necessary. One of the focus areas for the analysis shall be the 403 use of prescription drugs. The analysis shall be used in managed 404 care plan capitation rate-setting processes provided under this 405 part. 406 3. The agency shall make encounter data available to those 407 plans accepting enrollees who are assigned to them from other 408 plans leaving a region. 409 4. The agency shall annually produce a report entitled 410 “Analysis of Potentially Preventable Health Care Events of 411 Florida Medicaid Enrollees.” The report must include, but need 412 not be limited to, an analysis of the potentially preventable 413 hospital emergency department visits, hospital admissions, and 414 hospital readmissions that occurred during the previous state 415 fiscal year which may have been prevented with better access to 416 primary care, improved medication management, or better 417 coordination of care, reported by age, eligibility group, 418 managed care plan, and region, including conditions contributing 419 to each potentially preventable event or category of potentially 420 preventable events. The agency may include any other data or 421 analysis parameters to augment the report which it deems 422 pertinent to the analysis. The report must demonstrate trends 423 using applicable historical data. The agency shall submit the 424 report to the Governor, the President of the Senate, and the 425 Speaker of the House of Representatives by October 1, 2024, and 426 each October 1 thereafter. The agency may contract with a third 427 party vendor to produce the report required under this 428 subparagraph. 429 (f) Continuous improvement.—The agency shall establish 430 specific performance standards and expected milestones or 431 timelines for improving performance over the term of the 432 contract. 433 1. Each managed care plan shall establish an internal 434 health care quality improvement system, including enrollee 435 satisfaction and disenrollment surveys. The quality improvement 436 system must include incentives and disincentives for network 437 providers. 438 2. Each managed care plan must collect and report the 439 Healthcare Effectiveness Data and Information Set (HEDIS) 440 measures, the federal Core Set of Children’s Health Care Quality 441 measures, and the federal Core Set of Adult Health Care Quality 442 Measures, as specified by the agency. Each plan must collect and 443 report the Adult Core Set behavioral health measures beginning 444 with data reports for the 2025 calendar year. Each plan must 445 stratify reported measures by age, sex, race, ethnicity, primary 446 language, and whether the enrollee received a Social Security 447 Administration determination of disability for purposes of 448 Supplemental Security Income beginning with data reports for the 449 2026 calendar year. A plan’s performance on these measures must 450 be published on the plan’s website in a manner that allows 451 recipients to reliably compare the performance of plans. The 452 agency shall use the measures as a tool to monitor plan 453 performance. 454 3. Each managed care plan must be accredited by the 455 National Committee for Quality Assurance, the Joint Commission, 456 or another nationally recognized accrediting body, or have 457 initiated the accreditation process, within 1 year after the 458 contract is executed. For any plan not accredited within 18 459 months after executing the contract, the agency shall suspend 460 automatic assignment under ss. 409.977 and 409.984. 461 (g) Program integrity.—Each managed care plan shall 462 establish program integrity functions and activities to reduce 463 the incidence of fraud and abuse, including, at a minimum: 464 1. A provider credentialing system and ongoing provider 465 monitoring, including maintenance of written provider 466 credentialing policies and procedures which comply with federal 467 and agency guidelines; 468 2. An effective prepayment and postpayment review process 469 including, but not limited to, data analysis, system editing, 470 and auditing of network providers; 471 3. Procedures for reporting instances of fraud and abuse 472 pursuant to chapter 641; 473 4. Administrative and management arrangements or 474 procedures, including a mandatory compliance plan, designed to 475 prevent fraud and abuse; and 476 5. Designation of a program integrity compliance officer. 477 (h) Grievance resolution.—Consistent with federal law, each 478 managed care plan shall establish and the agency shall approve 479 an internal process for reviewing and responding to grievances 480 from enrollees. Each plan shall submit quarterly reports on the 481 number, description, and outcome of grievances filed by 482 enrollees. 483 (i) Penalties.— 484 1. Withdrawal and enrollment reduction.—Managed care plans 485 that reduce enrollment levels or leave a region before the end 486 of the contract term must reimburse the agency for the cost of 487 enrollment changes and other transition activities. If more than 488 one plan leaves a region at the same time, costs must be shared 489 by the departing plans proportionate to their enrollments. In 490 addition to the payment of costs, departing provider services 491 networks must pay a per-enrollee penalty of up to 3 months’ 492 payment and continue to provide services to the enrollee for 90 493 days or until the enrollee is enrolled in another plan, 494 whichever occurs first. In addition to payment of costs, all 495 other departing plans must pay a penalty of 25 percent of that 496 portion of the minimum surplus maintained pursuant to s. 497 641.225(1) which is attributable to the provision of coverage to 498 Medicaid enrollees. Plans shall provide at least 180 days’ 499 notice to the agency before withdrawing from a region. If a 500 managed care plan leaves a region before the end of the contract 501 term, the agency shall terminate all contracts with that plan in 502 other regions pursuant to the termination procedures in 503 subparagraph 3. 504 2. Encounter data.—If a plan fails to comply with the 505 encounter data reporting requirements of this section for 30 506 days, the agency must assess a fine of $5,000 per day for each 507 day of noncompliance beginning on the 31st day. On the 31st day, 508 the agency must notify the plan that the agency will initiate 509 contract termination procedures on the 90th day unless the plan 510 comes into compliance before that date. 511 3. Termination.—If the agency terminates more than one 512 regional contract with the same managed care plan due to 513 noncompliance with the requirements of this section, the agency 514 shall terminate all the regional contracts held by that plan. 515 When terminating multiple contracts, the agency must develop a 516 plan to provide for the transition of enrollees to other plans, 517 and phase in the terminations over a time period sufficient to 518 ensure a smooth transition. 519 (j) Prompt payment.—Managed care plans shall comply with 520 ss. 641.315, 641.3155, and 641.513. 521 (k) Electronic claims.—Managed care plans, and their fiscal 522 agents or intermediaries, shall accept electronic claims in 523 compliance with federal standards. 524 (l) Fair payment.—Provider service networks must ensure 525 that no entity licensed under chapter 395 with a controlling 526 interest in the network charges a Medicaid managed care plan 527 more than the amount paid to that provider by the provider 528 service network for the same service. 529 (m) Itemized payment.—Any claims payment to a provider by a 530 managed care plan, or by a fiscal agent or intermediary of the 531 plan, must be accompanied by an itemized accounting of the 532 individual claims included in the payment including, but not 533 limited to, the enrollee’s name, the date of service, the 534 procedure code, the amount of reimbursement, and the 535 identification of the plan on whose behalf the payment is made. 536 (n) Provider dispute resolution.—Disputes between a plan 537 and a provider may be resolved as described in s. 408.7057. 538 (o) Transparency.—Managed care plans shall comply with ss. 539 627.6385(3) and 641.54(7). 540 (p) Third-party administrators.—The agency′s contract with 541 a managed care plan must require that any third-party 542 administrative entity contracted by the plan adheres to all 543 pertinent requirements of the Medicaid program placed on the 544 plan under the plan′s contract with the agency. 545 (3) ACHIEVED SAVINGS REBATE.— 546 (h) The following may not be included as allowable expenses 547 in calculating income for determining the achieved savings 548 rebate: 549 1. Payment of achieved savings rebates. 550 2. Any financial incentive payments made to the plan 551 outside of the capitation rate. 552 3. Any financial disincentive payments levied by the state 553 or Federal Government. 554 4. Expenses associated with any lobbying or political 555 activities. 556 5. The cash value or equivalent cash value of bonuses of 557 any type paid or awarded to the plan’s executive staff, other 558 than base salary. 559 6. Reserves and reserve accounts. 560 7. Administrative costs, including, but not limited to, 561 reinsurance expenses, interest payments, depreciation expenses, 562 bad debt expenses, and outstanding claims expenses in excess of 563 actuarially sound maximum amounts set by the agency. 564 8. Payments to affiliates as defined in s. 409.962 in 565 excess of market rates. 566 567 The agency shall consider these and other factors in developing 568 contracts that establish shared savings arrangements. 569 (4) MEDICAL LOSS RATIOS RATIO.— 570 (a) If required by federal regulations or as a condition of 571 a waiver, the agency must may calculate a medical loss ratios 572 ratio for all managed care plans contracted with the agency 573 under this part. The calculations must calculation shall use 574 uniform financial data collected from all plans and shall be 575 computed for each plan on a statewide basis. If a plan 576 participates in the managed medical assistance program, the 577 long-term care managed care program, or the pilot program for 578 individuals with developmental disabilities, the agency must 579 calculate medical loss ratios for the plan’s participation in 580 each program separately and, if the plan participates in more 581 than one of these programs, for the plan’s overall participation 582 in statewide Medicaid managed care. Medical loss ratios must be 583 calculated and The method for calculating the medical loss ratio 584 shall meet the following criteria: 585 (a) Except as provided in paragraphs (b) and (c), 586 expenditures must shall be classified in a manner consistent 587 with 42 C.F.R. part 438 45 C.F.R. part 158. 588 (b) The agency shall report medical loss ratios quarterly 589 and annually for each managed care plan contracted with the 590 agency under this part to the Governor, the President of the 591 Senate, and the Speaker of the House of Representatives no later 592 than 6 months after the end of each such period Funds provided 593 by plans to graduate medical education institutions to 594 underwrite the costs of residency positions shall be classified 595 as medical expenditures, provided the funding is sufficient to 596 sustain the positions for the number of years necessary to 597 complete the residency requirements and the residency positions 598 funded by the plans are active providers of care to Medicaid and 599 uninsured patients. 600 (c) Before final determination of the medical loss ratio 601 for any period, a plan may contribute to a designated state 602 trust fund for the purpose of supporting Medicaid and indigent 603 care and have the contribution counted as a medical expenditure 604 for the period. Funds contributed for this purpose shall be 605 deposited into the Grants and Donations Trust Fund. 606 (5) AFFILIATED ENTITIES AND RELATED PARTIES.— 607 (a) The agency shall ensure oversight of affiliated 608 entities and related parties paid by managed care plans under 609 this part, including, but not limited to, examining financial 610 records and self-referral data of any managed care plan 611 providing services within the statewide managed care program 612 which uses affiliated entities and related parties. 613 (b) The agency shall consider data examined under paragraph 614 (a) and the findings of the annual assessment required under s. 615 409.9675(4) when developing managed care plan capitation rates 616 under this part. 617 Section 5. Effective January 1, 2027, paragraph (f) of 618 subsection (3) of section 409.967, Florida Statutes, is amended, 619 and paragraph (g) of that subsection is republished, to read: 620 409.967 Managed care plan accountability.— 621 (3) ACHIEVED SAVINGS REBATE.— 622 (f) Achieved savings rebates validated by the certified 623 public accountant are due within 30 days after the report is 624 submitted. Except as provided in paragraph (h), the achieved 625 savings rebate is established by determining pretax income as a 626 percentage of revenues and applying the following income sharing 627 ratios: 628 1. One hundred percent of income up to and including 3 5 629 percent of revenue shall be retained by the plan. 630 2. Thirty Fifty percent of income above 3 5 percent and up 631 to 10 percent shall be retained by the plan, and the other 70 50 632 percent shall be refunded to the state and adjusted for the 633 Federal Medical Assistance Percentages. The state share shall be 634 transferred to the General Revenue Fund, unallocated, and the 635 federal share shall be transferred to the Medical Care Trust 636 Fund, unallocated. 637 3. One hundred percent of income above 10 percent of 638 revenue shall be refunded to the state and adjusted for the 639 Federal Medical Assistance Percentages. The state share shall be 640 transferred to the General Revenue Fund, unallocated, and the 641 federal share shall be transferred to the Medical Care Trust 642 Fund, unallocated. 643 (g) A plan that exceeds agency-defined quality measures in 644 the reporting period may retain an additional 1 percent of 645 revenue. For the purpose of this paragraph, the quality measures 646 must include plan performance for preventing or managing 647 complex, chronic conditions that are associated with an elevated 648 likelihood of requiring high-cost medical treatments. 649 Section 6. Section 409.9675, Florida Statutes, is created 650 to read: 651 409.9675 Affiliated entities and controlling interests; 652 reports required.— 653 (1) Each managed care plan contracted by the agency under 654 this part shall report all of the following by March 31, 2027, 655 for the prior calendar year, and annually thereafter, to the 656 agency and the Office of Insurance Regulation in a manner 657 prescribed by the agency: 658 (a) Any person controlled by or affiliated with the managed 659 care plan, including, but not limited to, any provider, provider 660 group, group practice defined in s. 456.053(3), or person 661 responsible for providing any pharmacy services, 662 pharmaceuticals, diagnostics, care coordination, care delivery, 663 health care services, medical equipment, administrative 664 services, or financial services for, to, or on behalf of the 665 managed care plan. 666 (b) Any affiliation of any kind or nature with any person 667 who has, either directly or indirectly through one or more 668 intermediaries, an investment or ownership interest representing 669 10 percent or more, shares common ownership with, or has an 670 investor or a holder of an ownership interest representing 10 671 percent or more with any person providing pharmacy services, 672 diagnostics, care coordination, care delivery, health care 673 services, medical equipment, administrative services, or 674 financial services for, to, or on behalf of the managed care 675 plan. 676 (2) For any affiliation reported by a managed care plan 677 under subsection (1), the report must include all of the 678 following: 679 (a) The percentage of ownership or control of any person or 680 affiliate with whom the managed care plan has had business 681 transactions totaling in the aggregate more than $25,000 during 682 the prior 12-month period in the annual achieved savings rebate 683 financial reporting required under s. 409.967(3) and 684 identification of the specific contract or contracts involved in 685 such business transactions. 686 (b) Any significant business transactions between the 687 managed care plan and any affiliated person during the 12-month 688 period in the annual achieved savings rebate financial reporting 689 required under s. 409.967(3). 690 (3) Each managed care plan shall report any change in 691 information required by subsection (1) to the agency and the 692 Office of Insurance Regulation in writing within 60 days after 693 the change occurs. 694 (4) By December 31, 2026, and annually thereafter, the 695 agency shall calculate, analyze, and publicly report on the 696 agency’s website an assessment of affiliated entity payment 697 transactions in the Medicaid program for medical benefit and 698 administrative costs as reported for purposes of the achieved 699 savings rebate. The baseline assessment, at a minimum, must 700 include achieved savings rebate transactions for the years 2021, 701 2022, and 2023; the amount and associated percentage of 702 affiliated entity payments within the medical loss ratio; and 703 the payment deviation percentages and associated amounts at the 704 Healthcare Common Procedure Coding System level for affiliated 705 entities as compared to nonaffiliated entities. The assessment 706 must also compare payment amounts for value-based or alternative 707 payment arrangements. 708 Section 7. Present paragraphs (b) through (x) of subsection 709 (1) of section 626.8825, Florida Statutes, are redesignated as 710 paragraphs (c) through (z), respectively, a new paragraph (b) is 711 added to that subsection, and present paragraph (u) of 712 subsection (1) and paragraphs (c) and (h) of subsection (3) of 713 that section are amended, to read: 714 626.8825 Pharmacy benefit manager transparency and 715 accountability.— 716 (1) DEFINITIONS.—As used in this section, the term: 717 (b) “Affiliated manufacturer” means a prescription drug 718 manufacturer permitted under chapter 499 or a private label 719 distributor as defined in 21 C.F.R. s. 207.1 which directly or 720 indirectly through one or more intermediaries: 721 1. Has an investment or ownership interest in a pharmacy 722 benefit manager holding a certificate of authority issued under 723 this part; 724 2. Shares common ownership with a pharmacy benefit manager 725 holding a certificate of authority issued under this part; or 726 3. Has an investor or a holder of an ownership interest 727 which is a pharmacy benefit manager holding a certificate of 728 authority issued under this part. 729 (v)(u) “Pharmacy benefits plan or program” means a plan or 730 program that pays for, reimburses, covers the cost of, or 731 provides access to discounts on pharmacist services provided by 732 one or more pharmacies to covered persons who reside in, are 733 employed by, or receive pharmacist services from this state. 734 1. The term includes, but is not limited to, health 735 maintenance organizations, health insurers, self-insured 736 employer health plans, discount card programs, and government 737 funded health plans, including the Statewide Medicaid Managed 738 Care program established pursuant to part IV of chapter 409 and 739 the state group insurance program pursuant to part I of chapter 740 110. 741 2. The term excludes such a plan or program under s. 430.84 742 or chapter 440. 743 (3) CONTRACTS BETWEEN A PHARMACY BENEFIT MANAGER AND A 744 PARTICIPATING PHARMACY.—In addition to other requirements in the 745 Florida Insurance Code, a participation contract executed, 746 amended, adjusted, or renewed on or after July 1, 2023, that 747 applies to pharmacist services on or after January 1, 2024, 748 between a pharmacy benefit manager and one or more pharmacies or 749 pharmacists, must include, in substantial form, terms that 750 ensure compliance with all of the following requirements, and 751 that, except to the extent not allowed by law, shall supersede 752 any contractual terms in the participation contract to the 753 contrary: 754 (c) A prohibition of financial clawbacks, reconciliation 755 offsets, or offsets to adjudicated claims. A pharmacy benefit 756 manager may not charge, withhold, offset, or recoup any direct 757 or indirect remuneration fees, dispensing fees, brand name or 758 generic effective rate adjustments through reconciliation, or 759 any other monetary charge, withholding, or recoupments as 760 related to discounts, multiple network reconciliation offsets, 761 adjudication transaction fees, and any other instance when an 762 amount a fee may be recouped from a pharmacy if such action 763 would result in a reduction in the amount paid to the pharmacy 764 or pharmacist. This prohibition does not apply to: 765 1. Any incentive payments provided by the pharmacy benefit 766 manager to a network pharmacy for meeting or exceeding 767 predefined quality measures, such as Healthcare Effectiveness 768 Data and Information Set measures; recoupment due to an 769 erroneous claim, fraud, waste, or abuse; a claim adjudicated in 770 error; a maximum allowable cost appeal pricing adjustment; or an 771 adjustment made as part of a pharmacy audit pursuant to s. 772 624.491. 773 2. Any recoupment that is returned to the state for 774 programs in chapter 409 or the state group insurance program in 775 s. 110.123. 776 (h) The pharmacy benefit manager shall provide a reasonable 777 administrative appeal procedure to allow a pharmacy or 778 pharmacist to challenge the maximum allowable cost pricing 779 information and the reimbursement made under the maximum 780 allowable cost as defined in s. 627.64741 for a specific drug as 781 being below the acquisition cost available to the challenging 782 pharmacy or pharmacist. 783 1. The administrative appeal procedure must include a 784 telephone number and e-mail address, or a website, for the 785 purpose of submitting the administrative appeal. The appeal may 786 be submitted by the pharmacy or an agent of the pharmacy 787 directly to the pharmacy benefit manager or through a pharmacy 788 service administration organization. The administrative appeal 789 process must allow a pharmacy or pharmacist the option to submit 790 an electronic spreadsheet or similar electronic document 791 containing a consolidated administrative appeal representing 792 multiple adjudicated claims that share the same drug and day 793 supply and have a date of service occurring within the same 794 calendar month. The pharmacy or pharmacist must be given at 795 least 30 business days after a maximum allowable cost update or 796 after an adjudication for an electronic claim or reimbursement 797 for a nonelectronic claim to file the administrative appeal. 798 2. The pharmacy benefit manager must respond to the 799 administrative appeal within 30 business days after receipt of 800 the appeal. 801 3. If the appeal is upheld, the pharmacy benefit manager 802 must: 803 a. Update the maximum allowable cost pricing information to 804 at least the acquisition cost available to the pharmacy; 805 b. Permit the pharmacy or pharmacist to reverse and rebill 806 the claim in question; 807 c. Provide to the pharmacy or pharmacist the national drug 808 code on which the increase or change is based; and 809 d. Make the increase or change effective for each similarly 810 situated pharmacy or pharmacist who is subject to the applicable 811 maximum allowable cost pricing information. 812 4. If the appeal is denied, the pharmacy benefit manager 813 must provide to the pharmacy or pharmacist the national drug 814 code and the name of the national or regional pharmaceutical 815 wholesalers operating in this state which have the drug 816 currently in stock at a price below the maximum allowable cost 817 pricing information. 818 5. Beginning August 15, 2026 Every 90 days, a pharmacy 819 benefit manager shall report to the office the total number of 820 appeals received and denied in the preceding quarter 90-day 821 period, with an explanation or reason for each denial, for each 822 specific drug for which an appeal was submitted pursuant to this 823 paragraph. The deadlines for each filing are March 1 for the 824 preceding year′s fourth quarter; May 15 for the year′s first 825 quarter; August 15 for the year′s second quarter; and November 826 15 for the year′s third quarter. 827 Section 8. Subsection (7) of section 626.8827, Florida 828 Statutes, is amended, and subsections (8), (9), and (10) are 829 added to that section, to read: 830 626.8827 Pharmacy benefit manager prohibited practices.—In 831 addition to other prohibitions in this part, a pharmacy benefit 832 manager may not do any of the following: 833 (7) Fail to comply with the requirements in s. 624.491 or 834 s. 626.8825, or breach contractual terms required under s. 835 626.8825. 836 (8) Prohibit or restrict a pharmacy from declining to 837 dispense a drug if the reimbursement rate for the drug is less 838 than the actual acquisition cost to the pharmacy. 839 (9) Reimburse a pharmacy less than it reimburses an 840 affiliate pharmacy. 841 (10) Maintain an ownership interest, investment interest, 842 or common ownership with an affiliated manufacturer, or share 843 any investor or holder of an ownership interest with an 844 affiliated manufacturer. 845 Section 9. Subsection (1) of section 627.42392, Florida 846 Statutes, is amended to read: 847 627.42392 Prior authorization.— 848 (1) As used in this section, the term “health insurer” 849 means an authorized insurer offering health insurance as defined 850 in s. 624.603, a managed care plan as defined in s. 409.962 s. 851 409.962(10), or a health maintenance organization as defined in 852 s. 641.19(12). 853 Section 10. Except as otherwise provided in this act and 854 except for this section, which shall take effect upon this act 855 becoming a law, this act shall take effect July 1, 2026.

Texto oficial de la Legislatura de Florida. El formato se adaptó para leerlo en Ratifi.